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Autosomal recessive congenital ichthyosis (ARCI) is a rare, clinically and genetically heterogeneous genodermatosis.
One gene (transglutaminase 1, on 14q11) and one additional locus (on 2q33-35, with an unidentified gene) have
been shown to be associated with a lamellar, nonerythrodermic type of ARCI. We performed a genomewide scan,
with 370 highly polymorphic microsatellite markers, on five affected individuals from one large Finnish family with
nonerythrodermic, nonlamellar ARCI. The only evidence for linkage emerged from markers in a 6.0-cM region
on chromosome 19p13.1-2. The maximum two-point LOD score of 7.33 was obtained with the locus D19S252,
and multipoint likelihood calculations gave a maximum location score of 5.2. The affected individuals share two
common core haplotypes, which makes compound heterozygosity possible. The novel disease locus is the third
locus linked to ARCI, supporting previous evidence for genetic heterogeneity of ARCI. This is also the first locus
for a nonlamellar, nonerythrodermic phenotype of ARCI.
Autosomal recessive congenital ichthyoses (ARCI) rep-
resent a clinically and genetically heterogeneous group
of relatively rare, inherited disorders of cornification.
Traditionally, ARCI patients are classified as having ei-
ther lamellar ichthyosis (LI [MIM 242300]) or congen-
ital ichthyosiformis erythroderma (CIE [MIM 242100])
(Williams and Elias 1985). Classically, patients with LI
are born as collodion babies encased in a plasticlike
membrane that, within a few weeks, changes into scaling
skin. In adulthood, the scales are large and brownish
and there is ectropion of the eyes and, possibly, alopecia.
In CIE, scales are thinner and erythrodermia is promi-
nent. There is a continuum between these two clinical
pictures, and precise diagnosis is sometimes hard to
make.
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Two chromosomal loci, 14q11 and 2q33-q35, are
known to be associated with LI (Russell et al. 1994;
Parmentier et al. 1996). The transglutaminase 1 gene
(TGM1; keratinocyte transglutaminase) on 14q11,
whose product catalyzes the formation of cornified cell
envelope, has been demonstrated to be defective in some
patients with LI (Huber et al. 1995; Russell et al. 1995).
However, only a fraction of patients with LI have TGM1
mutations, confirming the genetic heterogeneity of the
disease, (Parmentier et al. 1995; Laiho et al. 1997). The
altered gene, on locus 2q33-q35, is still unknown.
Finland has been a representative example of the
power of a genetic isolate in the cloning of inherited
disease genes. Religious and linguistic barriers, geopo-
litical position, and, most importantly, geography have
ensured that the Finns remained in local and national
isolation. This isolation has caused the presence of sev-
eral genetically inherited diseases, grouped under the la-
bel “Finnish disease heritage,” including ∼30 mostly re-
cessive genetic traits that are exceptionally common in
Finland and rare among other populations. Internal iso-
lates within the country have proven to be beneficial for
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Figure 1 Pedigree and haplotypes of the family with nonlamellar, nonerythrodermic ARCI linked to chromosome 19. Persons marked
with an asterisk (*) were included in the genome scan. Ages of the affecteds are as follows: patient 5: 54 years old, patient 6: 12 years old,
patient 7: 11 years old, patient 8: 8 years old, and patient 9: 17 years old.
mapping of disease loci as well as traits that are not
overrepresented in the country (Norio et al. 1973; Pel-
tonen et al. 1999).
We have previously reported a TGM1mutation screen
of 38 Finnish families with ARCI (Laiho et al. 1997).
In 13 families, a TGM1 mutation was found, but in 25
families, no TGM1 mutation could be identified. Here
we present results from a genomewide scan in one family
with ARCI, from an internal isolate in Finland (without
a TGM1 mutation), with only five affected family mem-
bers. We assigned a third ARCI locus on chromosome
19p13.1-p13.2. It is the first locus to be associated with
nonlamellar, nonerythrodermic ARCI.
The diagnosis of ARCI was made at the Department
of Dermatology, Helsinki University Central Hospital,
and was based on electron microscopy. X-linked ich-
thyosis was excluded by measurement of steroid sulfate
activity (from patient 6; fig. 1), and the clinical picture
did not indicate X-linked ichthyosis. In histologic ex-
amination, the granular layer was present in all patients,
excluding clear-cut ichthyosis vulgaris. The family an-
alyzed in the linkage study (fig. 1) originates from a
known genetic subisolate in Finland, the archipelago of
Larsmo at the coast of Ostrobothnia. None of the other
37 families originate from Larsmo. The study protocol
was accepted by the Ethical Board of the Helsinki Uni-
versity Central Hospital.
All affected individuals displayed a nonlamellar, non-
erythrodermic phenotype not directly resembling either
classic LI or classic CIE, although such patients can be
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Figure 2 A, Skin of patient 6 (8 years old at time of photograph).
On the dorsal aspects of the upper arms, fine, white, nonlamellar
scaling is seen, demonstrating the mildness of scaling. Erythrodermia
is not present. B, The palms of patient 6 show hyperkeratotic, hy-
perlinear skin. Papules on the volar surface of the wrist are a conse-
quence of atopic dermatitis.
Figure 3 Electron micrograph of two cells of the epidermis of
patient 6. Between the granular and keratin layer, in the keratinization
line, there are pathological vacuolated keratinosomes without lamellar
structures. Above the keratinization line, inside the horny cell, there
is one lipid vacuole with some remnants of lamellar structures (original
magnification # 25,000).
diagnosed as having CIE. Scales in the skin were fine
and white (fig. 2A), and neither erythrodermia nor ec-
tropion was present. Scaling was more prominent in the
knees, ankles, and ears. Palms and soles appeared to be
hyperlinear (fig. 2B). Patients 6–8 were born as collodion
babies, whereas patients 5 and 9 were ichthyotic at birth.
Patients 6–8 had atopic dermatitis and patients 7 and 8
had asthma, but these conditions were also present in
unaffected family members. In addition, patient 5 had
normotensive hydrocephalus that was interpreted not to
be associated with ichthyosis. Only a few changes were
seen in electron microscopic studies of the affected in-
dividuals, including minor abnormalities in keratino-
somes, which suggest a functional rather than a struc-
tural alteration (fig. 3).
Genomic DNA for genotyping was extracted from leu-
kocytes of peripheral venous EDTA blood (5 ml) by
standard procedures (Sambrook et al. 1987). DNA was
amplified by means of the touchdown-PCR procedure
(Don et al. 1991). PCR products were then pooled so
that, at most, four PCR products of different sizes were
pooled together, and gel electrophoresis was run on an
ALFexpress automated sequencer (Pharmacia Biotech).
Genotypes were analyzed by the AlleleLinks 1.0 soft-
ware package (Pharmacia Biotech).
The candidate-gene approach was used first. The only
known gene for ichthyotic diseases—TGM1, on chro-
mosome 14q11—was excluded as the disease gene by
SSCP analysis (Orita et al. 1989; Laiho et al. 1997) and
by measurement of TGM1 activity as described by
Huber et al. (1997). By genotyping and haplotype anal-
ysis, we also excluded five possible chromosomal loci:
(1) the TGM2 and TGM3 locus in 20q11.2 (D20S107
and D20S119); keratin (KRT) loci (2) in 17q (D17S846
and D17S857) and (3) in 12q11-q13 (D12S368 and
D12S137); (4) a second locus for LI in 2q33-q35
(D2S143, D2S128, and D2S157); and (5) the epidermal
differentiation complex in 1q (D1S514 and D1S2345;
data not shown).
After exclusion of the candidate genes, the power of
our study samples targeting only one family with five
affected members was tested by simulation analysis. This
provided a maximum expected LOD score of 3.57 and
a mean expected LOD score of 1.36 at recombination
fraction (v) 0.010, calculated with 1,000 replicants. A
genomewide scan was performed with 370 highly poly-
morphic, fluorescently labeled microsatellite markers
from the Cooperative Human Linkage Center Weber set
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Figure 4 Order of loci and approximate distances between the
loci on chromosome 19p13.1-p13.2. Markers were obtained from the
Genome Database. The order and the distances of the physical map
are based on metric physical map of chromosome 19 created by the
Human Genome Center (Lawrence Livermore National Laboratory),
whereas the genetic distances are based on a genetic map of chro-
mosome 19 created by the Center for Medical Genetics (Marshfield
Medical Research Foundation). The precise location of the marker
D19S923 is unknown.
Table 1
Pairwise LOD Scores between ARCI and 11 Marker Loci
on Chromosome 19p
LOCUS
LOD SCORE AT v =
.0 .01 .05 .1 .2 .3
D19S914 1.84 1.78 1.56 1.30 .82 .42
D19S923 2.84 4.45 4.64 4.30 3.28 2.13
D19S226 2.04 3.40 3.60 3.27 2.34 1.36
D19S179 1.67 1.62 1.43 1.20 .79 .44
D19S415 3.49 3.39 3.00 2.53 1.65 .89
D19S929 1.27 .15 .59 .57 .29 .08
D19S432 .08 1.90 2.28 2.15 1.56 .89
D19S588 .72 .70 1.12 1.08 .72 .36
D19S252 7.33 7.18 6.59 5.83 4.26 2.67
D19S253 .65 .76 1.18 1.14 .76 .38
D19S411 3.41 3.33 2.98 2.55 1.69 .93
6A (Dubovsky et al. 1995). Some additional markers
from the Ge´ne´thon map were also genotyped (Dib et al.
1996). The average intermarker distance was 9.3 cM;
the largest gaps were 24 cM on chromosomes 1 and 20.
Linkage analysis was performed under the assumption
of autosomal recessive inheritance for the ARCI gene,
with an estimated gene frequency of 104 in the Finnish
population, and equal recombination rates for males and
females. Because of the early onset of the disease, com-
plete penetrance was used. Two-point LOD score cal-
culations were performed by means of the MLINK op-
tion of the LINKAGE software package (Lathrop et al.
1984; Cottingham et al. 1993). The SLINK option was
used to estimate the informativeness of the family ma-
terial used in the linkage analysis (Ott 1989; Weeks et
al. 1990). The SIMWALK2 program was used for lo-
cation score calculations as well as for determination of
the most likely haplotypes. SIMWALK2 uses a Markov
chain–Monte Carlo algorithm to traverse the space of
legal genetic-descent graphs, or inheritance vectors, for
each pedigree (Sobel and Lange 1996). Resulting loca-
tion scores are directly comparable to multipoint LOD
scores in log10 units. Allele frequencies were adopted
both from the pedigree and from the unaffecteds in the
Larsmo population.
The initial two-point linkage analysis of markers in
the genomewide scan revealed two interesting regions,
one on chromosome 9 (D9S158, LOD score 2.05) and
another on chromosome 19 (D19S432, LOD score 2.28
). The chromosome 9 area was excluded as a disease
locus by analysis of the haplotypes formed by four ad-
ditional microsatellite markers around the area of in-
terest (data not shown). In contrast, when 11 additional
microsatellite markers were analyzed from the chro-
mosomal region 19p13.1-2, they revealed a region of
∼6.0 cM in which all markers produced strong positive
LOD scores (fig. 4 and table 1). The maximum two-
point LOD score of 7.33 was obtained with locus
D19S252 ( ), whereas a maximum multipoint lo-v = 0.00
cation score of 5.2 was obtained in the close proximity
of the locus D19S914. Somewhat surprisingly, two al-
leles were identified in the disease chromosomes with
most markers.
The analysis of the 3-cM haplotype including the loci
D19S914, D19S923, D19S226, D19S179, D19S415,
D19S929, D19S432, D19S588, D19S252, D19S253,
and D19S411 revealed two core haplotypes: haplotype
1-1-6-1-1-2-1-2-3-2-2, inherited from ancestors 1 and 2,
and haplotype 2-2-3-1-1-1-2-3-3-3-2, inherited from an-
cestors 3 and 4 (fig. 1). Two adjacent loci in the middle
of the haplotype, D19S415 and D19S179, revealed ho-
mozygosity in all affected individuals. However, the fre-
quency of the D19S179 allele 1 was 68% in control
chromosomes analyzed from unaffected inhabitants of
the Larsmo archipelago, and the heterozygosity of the
locus D19S179 in CEPH families is only 0.68. The fre-
quency of allele 1 of locus D19S415 was 34%, and het-
erozygosity was 0.58. Thus, the significance of this find-
ing of homozygosity remains to be studied further and
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cannot so far be considered to be conclusive evidence
for a chromosomal region shared among all affected
individuals. The recombinations observed in patient 9
restricted the ARCI locus between the loci D19S914 and
D19S411. Patient 5 was homozygous for all the alleles
in the region, which was expected, considering the con-
sanguinity in the family. Yet her phenotype was similar
to those of the other patients.
Somewhat surprisingly, the haplotype analysis sug-
gests two different core haplotypes, which could predict
two ancestral mutations segregating in the pedigree, re-
sulting in the compound heterozygosity of patients. This
must be confirmed, since two adjacent loci, D19S179
and D19S415, revealed homozygosity in patients. A
finding suggestive of compound heterozygosity differs
from the mutation spectrum of diseases enriched in the
Finnish population, where one core haplotype and sub-
sequently one mutation are typically found in most of
the disease chromosomes (Ikonen et al. 1991; Ho¨glund
et al. 1996; Peltonen et al. 1999). However, our previous
screening for TGM1 mutations in ARCI patients re-
vealed 6 different mutations, and, for one of these mu-
tations, two haplotypes were observed, suggesting two
different origins of this mutation (Laiho et al. 1997).
ARCI cannot be considered part of the Finnish disease
heritage, and there is no evidence for the enrichment of
ARCI in Finland. It may be that ichthyoses represent
common inherited diseases in Finland and that a single
founder effect is not to be expected. On the other hand,
the archipelago of Larsmo is a well-known Finnish sub-
isolate. First inhabitants have been estimated to have
settled in the 13th century, but their origin is unknown.
The inhabitants had little contact with the mainland,
possibly because of difficulties in transportation and
communication. Therefore, random inbreeding is com-
mon. Large family trees have been traced in another
disease from Larsmo, tibial muscular dystrophy (Udd et
al. 1991). In a community like Larsmo, where consan-
guinity has been present relatively recently, a mixing of
two rare mutations of different origins into one consan-
guineous pedigree is possible (Haravuori et al. 1998).
However, exclusion of the possibility that the homozy-
gosity found with markers D19S179 and D19S415 in
the pedigree is a chance event and does not reflect the
presence of one old mutation in the pedigree remains to
be proved in further studies.
In previous genetic studies of ARCI, mainly LI patients
have been studied and have demonstrated association
with the two known ichthyosis loci (Huber et al. 1995;
Russell et al. 1995; Parmentier et al. 1996). Some groups
have also linked patients with CIE to TGM1 mutations
(Laiho et al. 1997; Hennies et al. 1998; Pigg et al. 1998).
However, the new locus on 19p is associated with non-
lamellar, nonerythrodermic CIE. The clinical picture of
the patients at birth can be severe, but, later, the scaling
is remarkably mild, resembling common dry skin, and
clearly differs from that in patients described in previous
linkage studies. Despite some common features (mild
clinical course, atopic dermatitis) with another mild
form of ichthyosis (ichthyosis vulgaris), patients in the
family studied have features that are clearly distinct from
ichthyosis vulgaris (Wells and Kerr 1966). Further stud-
ies will focus on identification of novel positional can-
didate genes with the chromosomal region 19p13.1-13.2
and will eventually expose the molecular defect in this
phenotype.
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